KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bio-Rad Laboratories (BIO) EPS (Basic) (2016 - 2025)

Historic EPS (Basic) for Bio-Rad Laboratories (BIO) over the last 17 years, with Q4 2025 value amounting to $26.41.

  • Bio-Rad Laboratories' EPS (Basic) rose 20409.78% to $26.41 in Q4 2025 from the same period last year, while for Dec 2025 it was $27.67, marking a year-over-year increase of 14233.17%. This contributed to the annual value of $27.87 for FY2025, which is 14264.08% up from last year.
  • Latest data reveals that Bio-Rad Laboratories reported EPS (Basic) of $26.41 as of Q4 2025, which was up 20409.78% from -$12.7 recorded in Q3 2025.
  • Bio-Rad Laboratories' 5-year EPS (Basic) high stood at $131.8 for Q3 2021, and its period low was -$112.5 during Q1 2022.
  • Moreover, its 5-year median value for EPS (Basic) was $2.99 (2023), whereas its average is -$1.86.
  • As far as peak fluctuations go, Bio-Rad Laboratories' EPS (Basic) plummeted by 44236.15% in 2022, and later skyrocketed by 54027.4% in 2024.
  • Bio-Rad Laboratories' EPS (Basic) (Quarter) stood at -$52.47 in 2021, then skyrocketed by 152.97% to $27.79 in 2022, then crashed by 56.92% to $11.97 in 2023, then plummeted by 311.89% to -$25.37 in 2024, then skyrocketed by 204.1% to $26.41 in 2025.
  • Its EPS (Basic) stands at $26.41 for Q4 2025, versus -$12.7 for Q3 2025 and $11.52 for Q2 2025.